Post-ischemic hyperglycemia exacerbates the development of cerebral ischemic neuronal damage through the cerebral

Yui Yamazaki1, Shinichi Harada, Shogo Tokuyama

  • 1Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Kobe Gakuin University, 1-1-3 Minatojima, Chuo-ku, Kobe 650-8586, Japan.

Brain Research
|October 20, 2012
PubMed

Insights

Post-ischemic hyperglycemia exacerbates brain injury by activating sodium-glucose transporters (SGLT). Inhibiting SGLT with phlorizin reduces neuronal damage, suggesting SGLT as a therapeutic target for stroke.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathophysiology

Background:

  • Post-ischemic hyperglycemia is linked to neuronal damage, but mechanisms remain unclear.
  • Sodium-glucose transporters (SGLT) mediate glucose uptake and cellular depolarization.
  • SGLT's role in cerebral ischemic stress-induced neuronal injury requires investigation.

Purpose of the Study:

  • To determine the involvement of SGLT in cerebral ischemic stress-induced neuronal damage.
  • To investigate the therapeutic potential of SGLT inhibition in stroke models.

Main Methods:

  • Middle cerebral artery occlusion (MCAO) model in male ddY mice.
  • Administration of phlorizin (SGLT inhibitor) and glucose via intraperitoneal and intracerebroventricular routes.
  • Assessment of fasting blood glucose, histological neuronal damage, and behavioral changes.

Main Results:

  • Phlorizin administration reduced hyperglycemia and neuronal damage in a dose-dependent manner.
  • Intracerebroventricular phlorizin suppressed neuronal damage without affecting blood glucose levels.
  • Exogenous glucose administration exacerbated neuronal damage, an effect reversed by phlorizin.

Conclusions:

  • Cerebral SGLT activation by post-ischemic hyperglycemia contributes to neuronal damage.
  • SGLT inhibition represents a potential therapeutic strategy for mitigating ischemic stroke injury.

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...